SCHEMBL14960716

SCHEMBL14960716

CC1(C)c2cc(-c3ccc4c(c3)c3cc5c(cc3n4-c3ccccc3)C(C)(C)c3ccccc3-5)ccc2-c2ccc(N(c3ccccc3)c3ccc(-c4ccccc4)cc3)cc21

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.33
TSPO P30536 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14960715 0.99 PDK2 (0.33) PDK2TSPO
SCHEMBL801982 0.98 PDK2 (0.31) PDK2
SCHEMBL782648 0.98 PDK2 (0.32) PDK2TSPO
SCHEMBL14960722 0.98 PDK2 (0.31) PDK2
SCHEMBL14960705 0.97 PGR (0.30) PDK2
SCHEMBL803029 0.96 PDK2 (0.32) PDK2TSPO
SCHEMBL14960719 0.96 PGR (0.31) PDK2
SCHEMBL14960703 0.96 TSPO (0.32) PDK2TSPO
SCHEMBL801980 0.96 TSPO (0.32) PDK2TSPO
SCHEMBL802058 0.96 TSPO (0.32) TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9196837-B2 Compound having indenocarbazole ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2015-11-24 US disclosed
US-9196837-B2 Compound having indenocarbazole ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2015-11-24 US disclosed
US-20130126856-A1 COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2013-05-23 US disclosed
US-20130126856-A1 COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2013-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130126856-A1 COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE SLCO2B1, SLCO1B1, SLCO2A1 PDK2 2761/4885TSPO 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.